Washington HB1971 ensures health plans cover a 12-month supply of prescription hormone therapy.
Washington HB1971 mandates that health plans offering prescription hormone therapy coverage must reimburse for a 12-month supply obtained at once, unless a smaller supply is requested or required by a provider. This applies to health plans issued or renewed after January 1, 2026. The bill also allows for temporary refill limits during shortages and maintains existing restrictions on refills in the last quarter of the plan year. Prescription hormone therapy includes drugs used to suppress, increase, or replace hormones, excluding glucagon-like peptide-1 and related agonists.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.